Shanghai OuDaXin New Material Technology Center
Finnrick has tested 38 samples from Shanghai OuDaXin New Material Technology Center across 3 products.
Finnrick Vendor Profile
Shanghai OuDaXin New Material Technology Center
Tracking 3 products
38 total samples tested
Last test 26 Jan 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 10 | 11 Aug 2025 | 26 Jan 2026 | |||||
| Tesamorelin | 7 | 11 Aug 2025 | 19 Jan 2026 | |||||
| Tirzepatide | 21 | 3 Jun 2025 | 15 Jan 2026 | |||||
Most recent Shanghai OuDaXin New Material Technology Center tests
Samples are tested in commercial labs
38
tests
3
products
Scores
AVGMINMAX
First
3 Jun 2025
Last
26 Jan 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 26 Jan 2026 | Retatrutide | View | 5mg | 5.22mg | +4.4% | 99.60% | (no batch ID) | White Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 19 Jan 2026 | Tesamorelin | View | 10mg | 10.1mg | +1.0% | 99.95% | (no batch ID) | Pink Label / Silver Crimp / Blue Cap | Lab E | Public | |
| 15 Jan 2026 | Tirzepatide | View | 10mg | 13mg | +30.0% | 99.17% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 15 Jan 2026 | Retatrutide | View | 30mg | 33.3mg | +11.0% | 99.90% | (no batch ID) | No Label / Green Crimp / Red Cap | Lab G | Public | |
| 9 Jan 2026 | Tirzepatide | View | 30mg | 28.6mg | -4.7% | 99.95% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab E | Public | |
| 7 Jan 2026 | Tirzepatide | View | 30mg | 34.7mg | +15.7% | 99.80% | (no batch ID) | White Label / Silver Crimp / Black Cap | Lab G | Public | |
| 7 Jan 2026 | Tirzepatide | View | 10mg | 10.5mg | +5.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / Green Cap | Lab G | Public | |